Feb 26, 2026 07:12AM
Feb 26, 2026 07:00AM
Feb 10, 2026 08:30AM
Nov 6, 2025 07:18AM
Nov 6, 2025 07:00AM
Oct 15, 2025 07:30AM
Aug 7, 2025 06:06AM Zai Lab Limited (ZLAB) Tops Q2 EPS by 37c ; Offers Guidance
Aug 7, 2025 06:00AM
Jul 10, 2025 07:30AM
May 8, 2025 06:10AM
May 8, 2025 06:00AM
Apr 14, 2025 07:30AM
Apr 2, 2025 07:04AM
Feb 27, 2025 06:11AM Zai Lab Limited (ZLAB) Tops Q4 EPS by 65c ; Offers Guidance
Feb 27, 2025 06:00AM
Jan 28, 2025 07:30AM
Nov 21, 2024 04:00AM
Nov 12, 2024 06:34AM
Nov 12, 2024 06:30AM
Oct 16, 2024 07:30AM
Aug 6, 2024 04:18PM Zai Lab Limited (ZLAB) Reports Q2 Loss of $0.82, Beats on Revenue
Aug 6, 2024 04:05PM
Jul 10, 2024 07:30AM
May 8, 2024 04:09PM
May 8, 2024 04:05PM
Apr 15, 2024 07:30AM
Feb 27, 2024 04:05PM
Jan 25, 2024 04:15PM Zai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024
Nov 7, 2023 04:08PM
Nov 7, 2023 04:05PM
Aug 10, 2023 05:57AM
Aug 7, 2023 04:43PM
Aug 6, 2023 09:00PM
Jun 6, 2023 08:07AM
Jun 6, 2023 08:05AM Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lu
May 9, 2023 04:25PM
Apr 20, 2023 07:30AM
Mar 1, 2023 04:26PM
Mar 1, 2023 04:01PM
Feb 9, 2023 07:30AM
Jan 5, 2023 07:35AM
Jan 5, 2023 07:34AM Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
Nov 9, 2022 04:02PM
Nov 9, 2022 04:01PM
Oct 18, 2022 07:30AM
Aug 9, 2022 04:20PM
Aug 9, 2022 04:05PM
Jul 19, 2022 07:38AM
Jun 3, 2022 08:01AM Zai Lab Limited (ZLAB) and Novocure (NVCR) Report Phase 2 Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint
Jun 3, 2022 08:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All